Volume 68 Received 28 October 2012 | |||||||||||
| |||||||||||
5)-abeo-5
-cholest-9-ene-3
,6
-diyl diacetateaBenemérita Universidad Autónoma de Puebla, Facultad de Ciencias Químicas, Ciudad Universitaria, Puebla, Pue. 72570, Mexico, and bUniversidad Autónoma de Nuevo León, UANL, Facultad de Ciencias Químicas, Av. Universidad S/N, Ciudad Universitaria, San Nicolás de los Garza, Nuevo León CP 66451, Mexico
Correspondence e-mail: sylvain_bernes@hotmail.com
The structure of the title steroid [alternative name: 3
,6
-diacetoxy-5
-methyl-19-norcholest-9(10)-ene], C31H50O4, confirms the generally accepted mechanism for the rearrangement of a cholestan-5
-ol derivative reported a century ago by Westphalen. The methyl group at position 10 of the starting material migrates to position 5 in the steroidal nucleus, while a
9 bond is formed, as indicated by the C=C bond length of 1.347 (4) Å. The methyl transposition leaves the 5R configuration unchanged, with the methyl oriented towards the
face. During the rearrangement, the steroidal B ring experiences a conformational distortion from chair to envelope with the C atom at position 6 as the flap. In the title structure, the isopropyl group of the side chain is disordered over two positions, with occupancies of 0.733 (10) and 0.267 (10). The carbonyl O atom in the acetyl group at C3 is also disordered with an occupancy ratio of 0.62 (4):0.38 (4).
For the initial report on the Westphalen rearrangement, see: Westphalen (1915
). For applications in steroid synthesis, see: Rodig et al. (1961
); Knights & Hanson (2004
); Pinto et al. (2008
, 2009
). For mechanistic aspects of this rearrangement, see: Kocovský & Cerný (1977
); Kocovský et al. (1979
); Kamernitskii et al. (1987
).
|
Data collection: XSCANS (Siemens, 1996
); cell refinement: XSCANS; data reduction: XSCANS; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: SHELXTL (Sheldrick, 2008
); software used to prepare material for publication: SHELXL97.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: FF2087 ).
We thank VIEP-BUAP for financial support.
Kamernitskii, A. V., Reshetova, I. G. & Chernov, S. V. (1987). Pharm. Chem. J. 21, 736-744. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Knights, S. G. & Hanson, J. R. (2004). J. Chem. Res. pp. 830-831. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Kocovský, P. & Cerný, V. (1977). Collect. Czech. Chem. Commun. 42, 2415-2437.
Kocovský, P., Cerný, V. & Turecek, F. (1979). Collect. Czech. Chem. Commun. 44, 234-245.
Pinto, R. M. A., Ramos Silva, M., Matos Beja, A., Salvador, J. A. R. & Paixão, J. A. (2009). Acta Cryst. C65, o214-o216.
![[details]](../../../../../../c/graphics/details.gif)
Pinto, R. M. A., Salvador, J. A. R., Le Roux, C., Carvalho, R. A., Ramos Silva, M., Matos Beja, A. & Paixão, J. A. (2008). Steroids, 73, 549-561.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Rodig, O. R., Brown, P. & Zaffaroni, P. (1961). J. Org. Chem. 26, 2431-2435.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Siemens (1996). XSCANS. Siemens Analytical X-ray Instruments Inc., Madison, Wisconsin, USA.
Westphalen, T. (1915). Chem. Ber. 48, 1064-1069. ![[ChemPort]](../../../../../../logos/chemportborder.gif)